The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond Thrombosis

Cancers

Hussein Echrish¹  Leigh A. Madden¹  John Greenman¹ 

[1] Centre for Biomedical Research, PGMI, University of Hull, Hull, HU6 7RX, UK; E-Mails:

关键词: pancreatic cancer;    thrombosis;    hemostasis;    tissue factor;    microparticles;   

DOI  :  10.3390/cancers3010267

来源: mdpi

【 摘 要 】

Laboratory evidence of aberrant coagulation is found in the majority of patients with advanced pancreatic cancer and a clinical consequence of this is the high incidence and prevalence of vascular thromboembolic events. Other sequelae are hypothesized to be the facilitation and acceleration of mechanisms that define the malignant phenotype, such as invasion, trafficking and anchoring, establishing the metastatic niche and inducing angiogenesis. We review the in vitro and preclinical evidence that supports the role of the coagulation apparatus in the metastatic process of pancreatic cancer, with a particular emphasis on interaction of this pathway with clinically-targeted growth factor receptor pathways. Links between hemostasis, angiogenesis and epidermal growth factor pathways and their significance as therapeutic targets are considered.

【 授权许可】

CC BY   
© 2011 by the authors; licensee MDPI, Basel, Switzerland.